Detalhe da pesquisa
1.
Treatment of Multiple Myeloma With Daratumumab in a Kidney Transplant Patient.
Am J Ther
; 28(4): e488-e491, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34228654
2.
Phase 1 clinical trial evaluating abatacept in patients with steroid-refractory chronic graft-versus-host disease.
Blood
; 131(25): 2836-2845, 2018 06 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-29549175
3.
Hypomethylating agent alters the immune microenvironment in acute myeloid leukaemia (AML) and enhances the immunogenicity of a dendritic cell/AML vaccine.
Br J Haematol
; 185(4): 679-690, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30828801
4.
Bone marrow stroma protects myeloma cells from cytotoxic damage via induction of the oncoprotein MUC1.
Br J Haematol
; 176(6): 929-938, 2017 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-28107546
5.
Generalized Acquired Cutis Laxa Associated with Monoclonal Gammopathy of Dermatological Significance.
Case Rep Dermatol Med
; 2020: 7480607, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32099688
6.
Alisertib plus induction chemotherapy in previously untreated patients with high-risk, acute myeloid leukaemia: a single-arm, phase 2 trial.
Lancet Haematol
; 7(2): e122-e133, 2020 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-31837959
7.
Anti-cancer vaccine therapy for hematologic malignancies: An evolving era.
Blood Rev
; 32(4): 312-325, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29475779
8.
DCOne as an Allogeneic Cell-based Vaccine for Multiple Myeloma.
J Immunother
; 40(9): 315-322, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28961609
9.
Challenges in vaccine therapy in hematological malignancies and strategies to overcome them.
Expert Opin Biol Ther
; 16(9): 1093-104, 2016 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-27220455